- Radiation Enhancement by The Combined Use of CPT-11 and Etoposide in Human Lung Cancer Cells
-
Kim JS, Kim JS, Cho MJ
- KMID: 2200235
- J Lung Cancer.
- 2002 Dec;1(1):60-65.
PURPOSE: To evaluate the radiation enhancement by a combination of CPT-11 and etoposide, with in vitro ionizing radiation. MATERIALS AND METHODS: H460 human lung carcinoma cells were plated, and treated... -
- CITED
-
- Close
- SHARE
-
- Close
- K-ras Gene Mutation in Non-Small Cell Lung Cancer
-
Yoon HJ, Ju JY, Cho GJ, Kim EJ, Park KH, Kim KS, Ko YC, Lim SC, Kim YC, Park KO, Park JT
- KMID: 2200234
- J Lung Cancer.
- 2002 Dec;1(1):55-59.
PURPOSE: Point mutation of the K-ras gene causes irreversible binding of GTP to the P21-ras protein, which induces nuclear transcription factors and enhances cellular proliferation. Point mutation of the K-ras... -
- CITED
-
- Close
- SHARE
-
- Close
- Fractionated Stereotactic Radiotherapy for Metastatic Brain Tumor in Non-Small Cell Lung Cancer
-
Cho MJ, Kim KH, Kim JS, Kim SH, Song SH, Song CJ, Lim SP, Kim SY, Kim JS
- KMID: 2200232
- J Lung Cancer.
- 2002 Dec;1(1):48-54.
PURPOSE: To evaluate the results of treatment with fractionated stereotactic radiotherapy for metastatic brain tumors in non-small cell lung cancer. MATERIALS AND METHODS: Between August 1997 and August 2001, 17... -
- CITED
-
- Close
- SHARE
-
- Close
- Preliminary Results of Stereotactic Body Frame Based Fractionated Radiosurgery on Consecutive Days for Primary Lung Cancer or Metastatic Lung Tumors
-
Lee SW, Choi EK, Park HJ, Ahn SD, Kim JH, Kim KJ, Yoon SM, Kim YS, Yi BY
- KMID: 2200231
- J Lung Cancer.
- 2002 Dec;1(1):41-47.
To evaluate the feasibility and treatment outcomes of stereotactic radiosurgery (SRS) using a stereotactic body frame (Precision TherapyTM), we prospectively reviewed 34 tumors of the 28 patients with primary or... -
- CITED
-
- Close
- SHARE
-
- Close
- Postoperative Adjuvant Chemotherapy and Radiotherapy for Stage II and III Non-Small Cell Lung Cancer (NSCLC)
-
Park JH, Lee SW, Choi EK, Chung WK, Shin KH, Ahn SD, Kim JH, Kim SW, Suh C, Lee JS, Kim WS, Kim DS, Kim DK, Park SI, Sohn KH
- KMID: 2200230
- J Lung Cancer.
- 2002 Dec;1(1):34-40.
PURPOSE: The role of postoperative adjuvant chemo-radiotherapy in the treatment of patients with non-small cell lung cancer (NSCLC) remains unclear. This study was undertaken to evaluate the survival outcomes, relapse... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemo-radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
-
Oh YT, Chun M, Choi JH, Lim HY, Kang S
- KMID: 2200228
- J Lung Cancer.
- 2002 Dec;1(1):29-33.
PURPOSE: Chemotherapy, followed by radiation therapy, improves the survival of patients with locally advanced non-small cell lung cancer (NSCLC). However, it is not clear whether chemotherapy, followed by concurrent chemo-radiation... -
- CITED
-
- Close
- SHARE
-
- Close
- DNA Methylation in Lung Cancer
-
Lee MK
- KMID: 2200226
- J Lung Cancer.
- 2002 Dec;1(1):23-28.
DNA modification in vertebrate genomes is confined to the self-complementary sequence CpG. Between 60% and 90% of CpGs are methylated at the 5 position of cytosine, and the remainder is... -
- CITED
-
- Close
- SHARE
-
- Close
- Radiotherapy for Locally Advanced Lung Cancer
-
Park CI, Choi EK
- KMID: 2200224
- J Lung Cancer.
- 2002 Dec;1(1):15-22.
Lung cancer is the leading cause of cancer deaths. Non-small cell lung cancer constitutes approximately 75% of lung cancers, and 40% will present as advanced stage IIIa or IIIb, which... -
- CITED
-
- Close
- SHARE
-
- Close
- Surgery for Locally Advanced Non-Small Cell Lung Cancer
-
Kim YT
- KMID: 2200223
- J Lung Cancer.
- 2002 Dec;1(1):9-14.
Surgical resection of locally advanced lung cancer is a challenging subject for thoracic surgeons. Although the operative mortality and morbidity have recently decreased, extended pulmonary resection still remains a high-risk... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Trend in The Treatment of Non-Small Cell Lung Cancer Non-small cell lung cancer
-
Lee KY
- KMID: 2200222
- J Lung Cancer.
- 2002 Dec;1(1):1-8.
(NSCLC) accounts for more than 80% of all lung cancer cases. Even though surgery plays a key role in the curative management of NSCLC, especially the stage I or II... -
- CITED
-
- Close
- SHARE
-
- Close
